Peter A. Lachenbruch Ph.D. University of California, Los Angeles 1965
Lachenbruch, Peter A.
Lachenbruch, Peter Anthony
VIAF ID: 36023477 (Personal)
Permalink: http://viaf.org/viaf/36023477
Preferred Forms
- 100 1 _ ‡a Lachenbruch, Peter A
-
- 100 1 0 ‡a Lachenbruch, Peter A.
-
- 100 1 _ ‡a Lachenbruch, Peter A.
- 100 1 _ ‡a Lachenbruch, Peter A.
-
- 100 1 _ ‡a Lachenbruch, Peter A.
-
-
- 100 0 _ ‡a Peter A. Lachenbruch ‡c Ph.D. University of California, Los Angeles 1965
4xx's: Alternate Name Forms (4)
Works
Title | Sources |
---|---|
Cyclosporine in systemic sclerosis. Results of a forty-eight-week open safety study in ten patients | |
Daily selenium intake estimates for residents of arsenic-endemic areas | |
Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index | |
Discriminant analysis | |
Early undifferentiated connective tissue disease: III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis) | |
Effect of timing of administration and quantity of blood transfusion on cadaver renal transplant survival | |
Effects of misclassifications on statistical inferences in epidemiology. | |
An efficacy study of electroconvulsive therapy and antidepressants in the treatment of primary depression | |
Emotional and cognitive changes in pregnancy and early puerperium. | |
Estimates of fecundability from a truncated distribution of conception times | |
Estimates of parameters in a probability model for first livebirth interval. | |
EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report | |
The factor VIII:C level is lower in daughters of hemophilia A subjects | |
Fatalities caused by TRALI. | |
Fraud in Medical Research | |
Genital tract abnormalities and female sexual function impairment in systemic sclerosis | |
Guest authorship, mortality reporting, and integrity in rofecoxib studies. | |
Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease-modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic Sclerosis | |
Hanbetsu bunseki | |
Health response by questionnaire in arsenic-exposed populations | |
Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three-year, parallel, randomized, double-blind study | |
Intent-to-treat analysis and preventive vaccine efficacy. | |
International consensus on preliminary definitions of improvement in adult and juvenile myositis. | |
Interrelationships between pulmonary and extrapulmonary involvement in systemic sclerosis. A longitudinal analysis | |
Is the relationship between supine blood pressure and postural changes in blood pressure artefactual? Results from the Kuopio Ischemic Heart Disease Risk Factor Study. | |
Knowledge of fraud among biostatisticians. | |
Lot consistency as an equivalence problem | |
The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis | |
Motivational factors affecting contraceptive use. | |
Motivational factors in abortion patients. | |
Multiple reading procedures: the performance of diagnostic tests | |
Neopterin and quinolinic acid are surrogate measures of disease activity in the juvenile idiopathic inflammatory myopathies. | |
Normal scores for nine maneuvers of the Childhood Myositis Assessment Scale | |
Observations on the relationship between frequency and timing of intercourse and the probability of conception | |
The odds ratio | |
On Determining the Effects of Therapy on Disease Damage in Non- randomized Studies with Multiple Treatments: A study of Juvenile Myositis. | |
On the sample size for studies based upon McNemar's test | |
On using microcomputers in statistical analysis | |
Opening the adaptive toolbox | |
Phase II study of cis-dischlorodiammineplatinum(II) in stage IVB Hodgkin's disease | |
Poisson distribution to assess actinic keratoses in xeroderma pigmentosum | |
Post-partum depression in Southern black women | |
Potential use of the scan statistic for quality control in blood product manufacturing | |
Power and sample size requirements for two-part models | |
Practice based evaluation of the longterm benefit of second line agents in rheumatoid arthritis | |
Preliminary validation and clinical meaning of the cutaneous assessment tool in juvenile dermatomyositis | |
Preparation and administration of chemotherapy. Haematological consequences for hospital-based nurses | |
Preventive vaccines against bioterrorism: evaluation of efficacy and safety | |
Proper metrics for clinical trials: transformations and other procedures to remove non-normality effects | |
Protective sensation in the hand and its correlation to the ninhydrin sweat test following nerve laceration | |
Quality assurance of clinical data: invited remarks. Remarks on quality enhancement in SENIC | |
Quantification of hepatitis B virus genomes and infectivity in human serum samples | |
Quantitative changes in the capillary bed during developing, peak, and stabilized cardiac hypertrophy in the spontaneously hypertensive rat | |
Rank analysis of covariance with right-censored data | |
Regional differences in brain electrical activity in dementia: use of spectral power and spectral ratio measures | |
Regression analysis of matched case-control data | |
Relationship of parental smoking and gas cooking to respiratory disease in children. | |
Reliability of Goniometers in Assessing Finger Joint Angle | |
RESIDENTIAL MOBILITY AND PSYCHIATRIC HELP-SEEKING | |
Respiratory and gastrointestinal illnesses in breast- and formula-fed infants | |
Respiratory illnesses in survivors of infant respiratory distress syndrome | |
Results of conservative surgery for middle ear cholesteatoma | |
Robust estimation of the exponential mean parameter for small samples: Complete and censored data | |
The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials. | |
Sample size considerations for establishing clinical bioequivalence of allergen formulations. | |
Scientific considerations for assessing biosimilar products. | |
Scientific factors and current issues in biosimilar studies | |
Sensitivity, specificity, and vaccine efficacy | |
Sexual dysfunction and signs of gynecologic cancer | |
Sister chromatid exchange analysis in nurses handling antineoplastic drugs | |
Skin score. A semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis | |
Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. | |
Some aspects of the application of internal pilot studies | |
Some Distributions on the Positive Real Line Which Have No Moments | |
Stability of sublines in the R3327-H rat prostatic tumor | |
Stratified initial values and change scores. | |
SurvCalc [CF] c1986: | |
Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report | |
Tutorial in biostatistics. Designing studies for dose response | |
Unmatched Observations in Matched Pairs Analyses | |
Use of models in evaluation of fertility dynamics: a review | |
Validation of the Childhood Health Assessment Questionnaire in the juvenile idiopathic myopathies. Juvenile Dermatomyositis Disease Activity Collaborative Study Group | |
Variable selection when missing values are present: a case study | |
Yield of cancer tissue from prostatic needle biopsy | |
判別分析 |